This inventor holds 19 USPTO granted patents, primarily in Organic Chemistry. Top assignees: Ajinomoto Co., Ltd., Katayama Seiyakusyo Co., Ltd.. Active years: 1981-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1981-2013
Areas of Expertise:
Title: **Eiji Nakanishi: Innovator in Pharmaceutical Patents**
Introduction
Eiji Nakanishi is a prominent inventor based in Kawasaki, Japan, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 19 patents, his work primarily focuses on the development of phenylalanine derivatives and their therapeutic applications.
Latest Patents
One of Nakanishi's latest patents encompasses specified phenylalanine derivatives and analogues. These compounds exhibit antagonistic activity to α4 integrin, making them valuable as therapeutic agents for various diseases associated with this integrin. This innovative approach demonstrates Nakanishi's commitment to advancing medicinal chemistry and improving health outcomes.
Career Highlights
Eiji Nakanishi has a distinguished career, having worked with reputable companies such as Ajinomoto Co., Ltd. and Katayama Seiyakusyo Co., Ltd. His work in these organizations has facilitated the growth of his expertise in the pharmaceutical domain, leading to the successful filing of numerous patents related to drug development.
Collaborations
Nakanishi has collaborated with notable colleagues, including Toshihiko Yoshimura and Masahiro Murata, to push the boundaries of research in their field. These partnerships exemplify the importance of teamwork and knowledge exchange in driving innovation and achieving groundbreaking results.
Conclusion
In conclusion, Eiji Nakanishi stands out as a notable inventor whose work continues to influence the pharmaceutical landscape. His numerous patents, particularly focusing on phenylalanine derivatives, showcase his dedication to creating effective therapeutic solutions. As the industry evolves, Nakanishi's contributions are likely to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile